logo
Streeting launches investigation into maternity services after families ‘gaslit'

Streeting launches investigation into maternity services after families ‘gaslit'

Wes Streeting said that 'up and down' the country 'maternity units are failing, hospitals are failing, trusts are failing, regulators are failing' and there was 'too much passing the buck'.
Mr Streeting, who has been meeting families who have lost babies to poor maternity care, told the Royal College of Obstetricians and Gynaecologists (RCOG) conference in London: 'Over the last year, I've been wrestling with how we tackle problems in maternity and neonatal units, and I've come to the realisation that while there is action we can take now, we have to acknowledge that this has become systemic.
'It's not just a few bad units. Up and down the country, maternity units are failing, hospitals are failing, trusts are failing, regulators are failing.
'There's too much obfuscation, too much passing the buck and giving lip service.'
Mr Streeting apologised on behalf of the NHS, having met families in Nottingham and around the country whose children have died or been injured.
Senior midwife Donna Ockenden is currently examining how hundreds of babies died or were injured in the care of Nottingham University Hospitals Trust.
Mr Streeting said: 'All of them have had to fight for truth and justice, they describe being ignored, gaslit, lied to, manipulated and damaged further by the inability for a trust to simply be honest with them that something has gone wrong.
'I want to say publicly how sorry I am, sorry for what the NHS has put them through, sorry for the way they've been treated since by the state and sorry that we haven't put this right yet, because these families are owed more than an apology. They're owed change, they're owed accountability and they're owed the truth.'
The Health Secretary said risk is 'considerably higher' than it should be for women and babies because of a 'crisis' in maternity and neo-natal services.
He added: 'Within the past 15 years, we've seen appalling scandals that blew the lid on issues ranging from care, safety, culture and oversight: Shrewsbury, Telford, East Kent, Nottingham.
'The last government responded with initiatives like Better Births in 2016 and the maternity transformation programme.
'But, despite improvements on some metrics, inequalities in maternal and neo-natal outcomes have become more visible, not less. The rate of late maternal deaths has been consistently rising.
'Babies of black ethnicity are twice as likely to be stillborn than babies of white ethnicity, and black women are still two to three times more likely to die during pregnancy or shortly after birth than white women.
'Tragically, that gap is closing slightly, but partly because more white women are dying in childbirth.'
Other high-profile scandals had deepened the public's mistrust in the state, Mr Streeting continued.
'From the Horizon Post Office scandal to the infected blood scandal, the degradation of responsibility and trust in our institutions is compounding a cynicism and malaise at the ability of British politics to deliver for people.
'This is a dangerous place for a country to be.
'If we do not admit the scale of the failure in maternity services, we're condemning ourselves to etching that mistrust deeper.
'If we cannot admit openly that we as institutions and as a state got this wrong, we'll never be able to fix it or rebuild that trust.
'Too many children have died because of state failure and I will not allow it to continue under my watch.'
The new investigation will consist of two parts.
The first will investigate trusts of greatest concern at the moment, including Leeds, Gloucester, Mid and South Essex and Sussex, 'to hold them to account for improvement', Mr Streeting said.
He added: 'I'm currently discussing with Leeds families the best way to grip the challenges brought to light in that trust by their campaigning, reports in the media and the latest Care Quality Commission (CQC) report, and I'll be ordering an investigation into nine specific cases identified by families in Sussex …'
The second part of the investigation will be a 'system-wide' look at maternity and neonatal care, uniting lessons from past maternity inquiries to create one 'clear set of actions' designed to improve national NHS care.
A National Maternity and Neonatal Taskforce, chaired by Mr Streeting, has also been set up, made up of experts and bereaved families.
The investigation will begin this summer and report back by December.
A new digital system will be rolled out to all maternity services by November to flag potential safety concerns in trusts, while an anti-discrimination programme to tackle inequalities is being launched.
Asked about the cost of the review, Mr Streeting said: 'I suspect it will be somewhat less than the enormous costs we pay in clinical negligence claims.
'Probably the most shocking statistic in this area is that we are paying out more in clinical negligence for maternity failures than we are spending on maternity services. That's how bad things are.
'So, putting together a review team, undertaking the level of analytical work required to produce a really good, high-quality evidence-based report is a drop in the ocean compared to the price of failure.'
Sir Jim Mackey, chief executive of NHS England, said: 'Despite the hard work of staff, too many women are experiencing unacceptable maternity care and families continue to be let down by the NHS when they need us most.
'This rapid national investigation must mark a line in the sand for maternity care – setting out one set of clear actions for NHS leaders to ensure high quality care for all.
'Transparency will be key to understanding variation and fixing poor care – by shining a spotlight on the areas of greatest failure we can hold failing trusts to account.
'Each year, over half a million babies are born under our care and maternity safety rightly impacts public trust in the NHS – so we must act immediately to improve outcomes for the benefit of mothers, babies, families and staff.'
The Royal College of Midwives (RCM) said maternity services are 'at, or even beyond, breaking point'.
RCM chief executive Gill Walton said: 'Every woman and family should leave maternity and neonatal services whole, happy and healthy.
'Yet we know that, for far too many, that isn't their experience.
'Systemic failings and a lack of attention to the warning signs have let those families down and let down the hardworking staff who are trying so hard to provide the care they deserve.
'Everyone involved in maternity services: the midwifery community, obstetricians, anaesthetists, sonographers and, of course, the women and families in their care; knows that maternity services are at, or even beyond, breaking point.
'This renewed focus and commitment by the Health Secretary to deliver change is welcome, and we will do everything we can to support him in doing so.'
Professor Ranee Thakar, president of the RCOG, said: 'The maternity workforce is on its knees, with many now leaving the profession.'
She said that 'for years, maternity units have had too few staff, too little time for training and lacked modern equipment and facilities, resulting in women and babies being harmed.'
She urged the Government to 'not to lose sight of funding and workforce shortages within this'.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mounjaro weight loss drug price to surge by 170% for Brits - except for ONE customer
Mounjaro weight loss drug price to surge by 170% for Brits - except for ONE customer

Daily Mirror

time26 minutes ago

  • Daily Mirror

Mounjaro weight loss drug price to surge by 170% for Brits - except for ONE customer

Eli Lilly is increasing the UK price of its weight-loss drug Mounjaro Eli Lilly is set to significantly hike the UK price of its weight-loss and diabetes medication Mounjaro, with some dosages expected to see a staggering 170 percent increase starting from September. ‌ The pharmaceutical giant has justified the price surge as an effort to "address pricing inconsistencies compared with other developed countries, including in Europe" and to ensure equitable global contributions towards funding medical research. ‌ The sharpest rise will affect the month's supply of the drug's highest doses, which will soar from £122 to £330. Smaller doses will experience increases ranging from 45 to 138 percent. It comes after a man, 30, puts shoulder pain down to gym aches, then doctors ask where he'd like to die. ‌ Despite these changes, Lilly has assured that the NHS will not be affected by the new list prices, pledging to maintain the current rates to preserve uninterrupted patient access. Private healthcare providers, who also offer the medication, will face the new prices but have the option to negotiate confidential discounts directly with Eli Lilly. This development occurs amidst political debates in the US, where ex-president Donald Trump has lambasted what he deems "foreign freeloaders" for enjoying lower pharmaceutical costs while Americans bear much higher expenses. In one address, he highlighted obesity treatments, recounting how a friend in London acquired the "fat shot drug" at a fraction of the US cost, reports the Daily Record. Research from the Rand Corporation indicates that drug prices in the US are typically almost triple those in several other advanced nations. The pharmaceutical sector has been mobilising to combat the potential danger of a "most favoured nation" strategy, which could tie American pricing to international rates. ‌ Lilly highlighted that the UK was amongst the earliest markets to receive Mounjaro and emphasised that its initial focus had been on delivering the medication to diabetic patients swiftly. "At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS changes in the environment and new clinical evidence supporting the value of Mounjaro, we are now aligning the list price more consistently to ensure fair global contributions to the cost of innovation," the firm stated. Talks between pharmaceutical companies and the UK Government regarding NHS drug costs have grown increasingly fraught, with deliberations about modifications to a clawback levy on pharmaceutical sales extending well beyond agreed timelines. ‌ The Government's latest proposals featured plans to increase spending on medications, though industry chiefs voiced exasperation over the absence of specifics or clarity regarding whether this would involve purchasing additional medicines or paying elevated prices for current treatments. The National Institute for Health and Care Excellence (NICE) has endorsed Mounjaro for as many as 3.4 million individuals across England. Nevertheless, worries about cost-effectiveness resulted in an arrangement for a staged introduction, beginning with approximately 250,000 patients presenting the most urgent clinical requirements during the initial three years. NHS England has assured that the forthcoming price alterations will not impact the provision of the medication to qualified patients suffering from obesity or diabetes. "Mounjaro is a cost-effective and valuable tool to support people to reach a healthier weight and the wider health and lifestyle benefits that offers," NHS England stated. The adjustments bring the UK's pricing more in line with the European mean, occurring amidst a period when drug manufacturers are acutely aware of how varying international prices might influence upcoming policy choices in the US.

Baroness Amos to lead NHS maternity and neonatal investigation
Baroness Amos to lead NHS maternity and neonatal investigation

South Wales Argus

time2 hours ago

  • South Wales Argus

Baroness Amos to lead NHS maternity and neonatal investigation

Baroness Amos was selected by Health Secretary Wes Streeting after bereaved families expressed a preference for someone with distance from the NHS who is able to bring a fresh pair of eyes to the role, the Department of Health and Social Care (DHSC) said. Mr Streeting has been meeting bereaved and harmed families who have been let down by maternity and neonatal services across the country, including in some of the worst affected trusts, DHSC added. In June, he announced that a national investigation into 'systemic' failures in NHS maternity care had been launched by the Government after families were 'gaslit' in their search for the truth. Baroness Amos is master of University College, Oxford, and was a UK Government minister and a senior official at the United Nations. Mr Streeting said: 'I have been appalled by the many harrowing stories I've heard from mothers and fathers let down by the NHS. 'Families asked for fresh eyes, independence and compassion – and that's why I've appointed Baroness Amos. Valerie has an outstanding record of leadership and driving change, nationally and internationally. She will work closely with families to uncover the truth, confront problems and drive the improvements needed so every woman and baby receives safe, high-quality care. 'Through our Plan for Change, we will rebuild the NHS to ensure no family suffers like this again.' Baroness Amos said: 'I will carry the weight of the loss suffered by families with me throughout this investigation. I hope that we will be able to provide the answers that families are seeking and support the NHS in identifying areas of care requiring urgent reform.' The investigation will look at up to 10 services in the country. It will also review the maternity and neonatal system, bringing together the findings of past reviews into one national set of actions, the DHSC said. It will begin work this summer and produce an initial set of national recommendations by December. The 10 maternity and neonatal units will be decided by Baroness Amos and her team, alongside the terms of reference of the investigation, which are being developed with families who have experiences of maternity and neonatal care, including in Leeds, Sussex and Nottingham, the DHSC added. The investigation is separate from the National Maternity and Neonatal Taskforce, which will be made up of a panel of experts and families, and chaired by Mr Streeting. Baroness Amos (PA) Gill Walton, chief executive of the RCM, said: 'We are pleased to hear of the appointment of Baroness Amos as chair of the rapid review. She has a reputation for taking a thoughtful and strategic approach and we welcome her fresh insight into maternity and neonatal safety. 'It is absolutely vital, though, that this review gets under way quickly. When he announced it in June, we welcomed Wes Streeting's commitment to publishing the review by Christmas, a promise he repeated at the Progress in Partnership summit on maternity and neonatal safety last month. 'However, we are already halfway through August, with no terms of reference, no sense of the trusts who are likely to be part of the review or no clarity on how the review will be conducted. 'Every woman and family should leave maternity and neonatal services whole, happy and healthy, and every member of maternity staff should start and end their shift knowing they have provided safe, good-quality care. 'At the moment, that simply isn't the case. Previous reviews and countless Care Quality Commission reports have flagged the same the systemic failings that are at the heart of the issues facing maternity and neonatal care issues time and time again: unsafe staffing, poor workplace cultures, and not listening to women. 'In spite of that, there has been no forward movement. Wes Streeting promised to change that. Thousands of midwives and maternity support workers, and the whole of the maternity community, are desperate for him to keep that promise and deliver the change we all want to see.' The RCM has also urged the review to look at examples of good maternity care, as well as where services are not meeting standards of care.

NHS struggles to improve under Labour as waiting lists rose in June and patients still facing delays in A&E
NHS struggles to improve under Labour as waiting lists rose in June and patients still facing delays in A&E

The Sun

time2 hours ago

  • The Sun

NHS struggles to improve under Labour as waiting lists rose in June and patients still facing delays in A&E

NHS LISTS GROW While NHS England said staff 'pulled out all the stops' in June the backlog increased for the second time this year THE NHS is struggling to get better under Labour, figures suggest. Waiting lists rose in June and there are still unacceptable numbers of patients facing day-long delays in A&E, they show. 1 Data confirmed the recent British Medical Association strike was less damaging than previous ones. And while NHS England said staff 'pulled out all the stops' in June the backlog increased for the second time this year, from 7.36million to 7.37million. Dr Becks Fisher, of the Nuffield Trust think tank, said: 'The figures show the NHS waiting list has gone up slightly after falling over most months this year.' She added: 'It is still treating fewer patients than are being referred.' Danielle Henry, of the Independent Healthcare Providers Network, added: 'The NHS needs to rapidly increase the amount of activity it delivers if it is going to successfully reduce waiting lists by one million each year.' Official figures show improvements to A&E delays, cancer treatment times and ambulance response times but doctors said the system was still struggling. Dr Nick Murch, of the Society for Acute Medicine, said: 'Clinicians across the UK are reporting this week as one of the worst they have experienced. "Figures show an unacceptable amount of people — 35,467 — waited over 12 hours in emergency departments, often suffering avoidable harm.' Lib Dem MP Helen Morgan said: 'This Government is doing no better than treading water.' Health Secretary Wes Streeting said: 'We are getting on with the job of delivering progress in the face of strike action, and we will continue to put patients first.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store